A critical review of COVID-19 course and vaccination in dermatology patients on immunomodulatory/biologic therapy: recommendations should not differ between non-pregnant and pregnant individuals

COVID-19 can have detrimental effects on immunosuppressed patients. Here, we evaluate the evidence regarding continuing immunomodulatory/biologic (IMBI) therapy in pregnant dermatology patients during the COVID-19 pandemic. Also, we discuss the risks of COVID-19 vaccination in pregnant dermatology p...

Descripción completa

Detalles Bibliográficos
Autores principales: Messas, Tassahil, Lim, Rachel K., Burns, Laura, Yumeen, Sara, Kroumpouzos, George
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10272467/
https://www.ncbi.nlm.nih.gov/pubmed/37332768
http://dx.doi.org/10.3389/fmed.2023.1121025

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10272467/
https://www.ncbi.nlm.nih.gov/pubmed/37332768
http://dx.doi.org/10.3389/fmed.2023.1121025

Ejemplares similares